CAMBRIDGE, Mass. & MENLO PARK, Calif.--(BUSINESS WIRE)--Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...
NEW YORK, NY, UNITED STATES, January 6, 2026 /EINPresswire.com/ — Panther Life Sciences announces expanded access to its high-precision Microarray Patch (MAP ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果